HEARING

Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs

HealthHouse119th Congress

Schedule

Date and time (ET)
April 1, 2025 at 10:15 AM
Location
Rayburn House Office Building · 2123

Witnesses

Mr. Carl D’Ruiz, MPH
Senior Science, Advocacy, and Business Development Manager for Beauty and Care, North America
Mr. Scott Faber
Senior Vice President, Government Affairs
Mr. Kevin Menzel
Member, Board of Directors, Consumer Healthcare Products Association;
Ms. Kim Wezik, MPH
Director of Advocacy
Mr. Douglas Troutman
Interim Co-Chief Executive Officer

Topics